ES2256232T3 - Metodos y composiciones para provocar una respuesta inmunitaria. - Google Patents

Metodos y composiciones para provocar una respuesta inmunitaria.

Info

Publication number
ES2256232T3
ES2256232T3 ES01930632T ES01930632T ES2256232T3 ES 2256232 T3 ES2256232 T3 ES 2256232T3 ES 01930632 T ES01930632 T ES 01930632T ES 01930632 T ES01930632 T ES 01930632T ES 2256232 T3 ES2256232 T3 ES 2256232T3
Authority
ES
Spain
Prior art keywords
chemotaxin
cells
apc
chemokine
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01930632T
Other languages
English (en)
Spanish (es)
Inventor
Thomas J. Schall
Dale Talbot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemocentryx Inc
Original Assignee
Chemocentryx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemocentryx Inc filed Critical Chemocentryx Inc
Application granted granted Critical
Publication of ES2256232T3 publication Critical patent/ES2256232T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
ES01930632T 2000-04-21 2001-04-20 Metodos y composiciones para provocar una respuesta inmunitaria. Expired - Lifetime ES2256232T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19883900P 2000-04-21 2000-04-21
US198839P 2000-04-21
US83481401A 2001-04-12 2001-04-12
US834814 2001-04-12

Publications (1)

Publication Number Publication Date
ES2256232T3 true ES2256232T3 (es) 2006-07-16

Family

ID=26894197

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01930632T Expired - Lifetime ES2256232T3 (es) 2000-04-21 2001-04-20 Metodos y composiciones para provocar una respuesta inmunitaria.

Country Status (9)

Country Link
EP (1) EP1274454B1 (enExample)
JP (1) JP4903342B2 (enExample)
AT (1) ATE314088T1 (enExample)
AU (2) AU2001257148B2 (enExample)
CA (1) CA2406853C (enExample)
DE (1) DE60116280T2 (enExample)
DK (1) DK1274454T3 (enExample)
ES (1) ES2256232T3 (enExample)
WO (1) WO2001080882A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361329B2 (en) 2000-04-21 2008-04-22 Chemocentryx, Inc. Compositions for inducing an immune response
WO2003035106A1 (en) * 2001-10-24 2003-05-01 Chemocentryx Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen
WO2009054873A2 (en) 2007-08-02 2009-04-30 Novimmune S.A. Anti-rantes antibodies and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE424217T1 (de) * 1997-12-11 2009-03-15 Univ Maryland Biotech Inst Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
KR20070039615A (ko) * 1998-02-27 2007-04-12 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 백신, 면역치료제 및 그의 이용 방법
DE69929432T2 (de) * 1998-04-22 2006-09-28 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Erhöhung der immunantworten bei genetischer immunisierung durch verwendung eines chemokins

Also Published As

Publication number Publication date
CA2406853A1 (en) 2001-11-01
JP4903342B2 (ja) 2012-03-28
JP2003534250A (ja) 2003-11-18
EP1274454A2 (en) 2003-01-15
CA2406853C (en) 2012-06-26
WO2001080882A3 (en) 2002-04-04
ATE314088T1 (de) 2006-01-15
DK1274454T3 (da) 2006-05-15
DE60116280T2 (de) 2006-09-21
AU5714801A (en) 2001-11-07
DE60116280D1 (de) 2006-02-02
WO2001080882A2 (en) 2001-11-01
AU2001257148B2 (en) 2006-03-30
EP1274454B1 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
TWI741241B (zh) 用於治療及/或預防異位性皮膚炎之il-31胜肽免疫原及其劑型
US20230285545A1 (en) Polypeptides, vaccine compositions, and use thereof for inducing immune response to sars-cov-2 in primates
JP2003526315A (ja) アミノ末端修飾を有するケモカイン
Matsushima et al. Thirty-five years since the discovery of chemotactic cytokines, interleukin-8 and MCAF: A historical overview
KR100943825B1 (ko) 면역 반응을 강화하는 방법과 조성물
US20020071825A1 (en) Methods and compositions for inducing an immune response
ES2256232T3 (es) Metodos y composiciones para provocar una respuesta inmunitaria.
US20220105163A1 (en) Peptide immunogens targeting interleukin 6 (il-6) and formulations thereof for immunotherapy of diseases impacted by il-6 dysregulation
Boraschi et al. Interleukin-1 and interleukin-1 fragments as vaccine adjuvants
Dikopoulos et al. Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naive CD8+ T cells in the mouse
US7361329B2 (en) Compositions for inducing an immune response
AU2001257148A1 (en) Methods and compositions for eliciting an immune response
WO2007042583A1 (es) Combinación inmunoe s t imuladora para profilaxis y tratamiento de hepatitis c
ES2225977T3 (es) Agonistas de interleuquina 4 selectivos para linfocitos t.
US20100331524A1 (en) Immunomodulatory protein and useful embodiments thereof
WO2003035106A1 (en) Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen
WO2002085409A2 (en) Methods and compositions for inducing an immune response to an antigen
CN106075431A (zh) 皮氨钙联合佐剂及含有皮氨钙联合佐剂的疫苗
Goeckeritz et al. Enhanced and sustained activation of human B cells by anti‐immunoglobulin conjugated to the EBV glycoprotein gp350
AU2005306186B2 (en) Immunotherapeutic formulations with Interleukin-2-neutralising capacity
US20050234004A1 (en) Compositions and methods of use of W-peptides
CN112300248B (zh) 一类促进猪机体产生广谱性免疫应答的多肽及其应用
García et al. Factors that influence the immunogenicity of human recombinant interferon alpha-2b in mice
HK40025696A (en) Peptide immunogens of il-31 and formulations thereof for the treatment and/or prevention of atopic dermatitis